๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Fatal reactivation of hepatitis B virus mutant following cytotoxic treatment

โœ Scribed by Jean-Charles Duclos-Vallee; Pierre Laurent-Puig; Marie-Anne Loriot; Catherine Buffet; David Malka; Gilles Pelletier; Patrick Marcellin; Serge Erlinger; Jean-Pierre Etienne


Book ID
118566478
Publisher
Elsevier Science
Year
1994
Tongue
English
Weight
105 KB
Volume
21
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Lamivudine in the treatment of hepatitis
โœ Yeo, Winnie; Steinberg, Joyce L.; Tam, John S.; Chan, Paul K.S.; Leung, Nancy W. ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 76 KB ๐Ÿ‘ 2 views

Hepatitis B virus (HBV) reactivation has been described in cancer patients who received cytotoxic/immunosuppressive therapy and may result in liver damage of varying degrees of severity. There is no known effective treatment. Lamivudine, a nucleoside analogue, has been found to suppress HBV replicat

Reactivation of precore mutant hepatitis
โœ Ming-Shen Dai; Jang-Jih Lu; Yeu-Chin Chen; Cherng-Lih Perng; Tsu-Yi Chao ๐Ÿ“‚ Article ๐Ÿ“… 2001 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 71 KB ๐Ÿ‘ 2 views

## BACKGROUND. A point mutation from G to A at nucleotide (nt) 1896 of the precore region of hepatitis B virus (HBV) DNA has been shown to be associated with fulminant and severe hepatitis. Further studies have suggested that this point mutation, together with additional mutations in the precore p